If you have been researching medical options for weight loss, there is a good chance you have already encountered GLP-1 medications. Semaglutide and tirzepatide, often recognized through brand names such as Ozempic, Wegovy and Mounjaro, have become a major part of the conversation around obesity and weight management. Their growing visibility has understandably led more people in Jamaica to ask whether these treatments could help them lose weight.
There is good reason for the interest. GLP-1 based therapies have changed the medical treatment of obesity and can produce meaningful weight loss in appropriate patients. The World Health Organization now recognizes GLP-1 therapies as a potential long-term treatment option for adults living with obesity, while emphasizing that medication should form part of comprehensive care rather than being viewed as a solution on its own.
The popularity of these treatments has also made the subject more confusing. Social media discussions frequently use terms such as GLP-1, peptide, Ozempic and weight loss injection as though they all describe the same thing. They do not. Different medications work through different biological pathways, have different clinical indications and may carry different considerations for individual patients.
That distinction is central to the approach at The Weight Clinic. We expect many patients to arrive already interested in GLP-1s, peptides or a particular medication, and there is nothing wrong with having done your research before speaking with a physician. The purpose of the medical consultation is to place that interest in the context of your health, weight history, current medications, previous treatment experience and goals so that an appropriate treatment strategy can be considered.
What exactly are GLP-1s?
GLP-1 stands for glucagon like peptide 1, a hormone produced naturally in the body that plays an important role in appetite, digestion and blood glucose regulation. Medicines that act on the GLP-1 pathway can help reduce appetite and food intake while influencing metabolic processes involved in blood sugar control. This is one reason the class first became prominent in diabetes care before becoming an important part of the wider medical conversation around obesity and weight management.
Not every medication now discussed alongside GLP-1s works in exactly the same way. Semaglutide acts as a GLP-1 receptor agonist, while tirzepatide targets both GLP-1 and GIP receptors. Other therapies currently being researched target additional metabolic pathways.
These distinctions are clinically important. Choosing a treatment should involve more than deciding which medication is newest, most popular or producing the most dramatic stories online. A physician needs to consider the individual patient, including medical history, medications, previous weight loss attempts, potential contraindications, treatment goals and the monitoring that may be required.
How effective are GLP-1 medications for weight loss?
Clinical research has shown that GLP-1 based treatments can produce significant weight loss in appropriate patients, although results vary considerably from one person to another. Treatment response can be influenced by the medication being used, the patient’s underlying health, adherence to treatment, nutrition, physical activity, side effects and the length of time treatment is continued.
This variability is important because the extraordinary attention surrounding these medications can sometimes create unrealistic expectations. Medical weight loss should not be approached as a guaranteed route to a particular number on the scale. The objective is to identify an appropriate treatment strategy, monitor how the individual responds and make clinical decisions as treatment progresses.
There is also a broader issue that is sometimes lost in discussions focused exclusively on medication. Obesity is increasingly understood as a chronic condition that may require ongoing management. WHO’s current guidance reflects this by placing GLP-1 therapies within a comprehensive approach to obesity care that can include medical treatment, nutrition, physical activity and longer term support.
Who should consider medical weight loss treatment?
People explore medical weight loss for many different reasons. Some have spent years moving through diets and exercise programmes without achieving the progress they want. Others can lose weight but repeatedly regain it. Some have developed health concerns associated with excess weight, while another increasingly common group consists of people who have learned about GLP-1s or peptide-based treatments and want to understand whether these newer medical options are appropriate for them.
Being interested in a medication does not necessarily mean that it is the right treatment for you. Medical history, existing health conditions, current medications and other individual factors can influence both the suitability of treatment and the way it should be managed.
This is why The Weight Clinic begins with a physician consultation rather than with the sale of a particular medication. Dr. Lorenzo Gordon reviews the patient’s health, weight history, medications, previous treatments and goals before discussing the available options. Where medical treatment is appropriate, the recommended treatment, monitoring requirements and associated costs can then be explained.
For a direct comparison of two of the most discussed options, see our guide to semaglutide vs tirzepatide for weight loss. For a broader explanation of the category, see peptides for weight loss.
Semaglutide, tirzepatide and peptide-based treatments
Semaglutide and tirzepatide are frequently discussed together, but they are not the same medication. Semaglutide acts on the GLP-1 receptor, while tirzepatide acts on both GLP-1 and GIP receptors. These differences in mechanism can affect how the treatments work and form part of the clinical considerations involved in choosing an appropriate therapy.
The wider category of peptide-based medicine is also attracting significant attention. Peptides are short chains of amino acids that can act as signalling molecules within the body, and a growing range of therapies use or mimic biological pathways associated with metabolism, appetite and other physiological functions. The term itself, however, does not tell a patient whether a particular therapy is appropriate, effective or safe for them.
This is an area where informed medical guidance becomes particularly valuable. Interest in newer therapies is moving quickly, and patients are increasingly encountering information through social media, podcasts, online communities and commercial suppliers before discussing it with a physician. A medical consultation provides an opportunity to separate general information about a treatment from the much more important question of whether that treatment makes sense for the individual patient.
What about side effects and safety?
GLP-1 therapies can cause side effects and are not appropriate for everyone. Commonly reported effects include nausea, vomiting, diarrhoea and constipation, although other adverse effects and medical considerations may also be relevant depending on the treatment and the individual patient.
Before treatment begins, a physician should review relevant aspects of the patient’s medical history and current medications and discuss expected benefits, material risks and appropriate monitoring. The patient’s response should then continue to be assessed during treatment rather than medication simply being provided without follow up.
The rapid growth in demand for GLP-1 medications has created another consideration. International health authorities have raised concerns about products obtained through informal or inappropriate channels, including unapproved and falsified products. Patients considering medical weight loss should therefore think not only about which treatment interests them, but also about the clinical system surrounding that treatment.
At The Weight Clinic, physician supervision is part of the treatment itself. It is not an additional service added after a medication has already been selected.
What happens at a Weight Clinic consultation?
Patients do not need to arrive at their consultation knowing exactly which medication they want. Equally, someone who has already spent considerable time researching semaglutide, tirzepatide, GLP-1s or peptide-based therapies does not need to hide that interest.
The consultation is an opportunity to discuss what you have been considering and place it within a proper medical assessment. Dr. Gordon reviews your health and medical history, weight history, current medications, previous treatments and goals. This provides the clinical context needed to discuss which options may be appropriate and whether additional information or testing may be required.
If treatment is recommended, the treatment plan, monitoring requirements and costs are explained before treatment begins. Medication is therefore one component of a wider medical weight management process rather than the starting point for every patient.
Losing weight is only part of the objective
The immediate reason most patients seek treatment is straightforward. They want to lose weight. The longer term challenge is making that progress meaningful and sustainable.
The Weight Clinic’s approach is built around three stages: LOSE. BUILD. SUSTAIN. The first objective is to help patients make meaningful progress using a treatment plan based on their health, goals and what is medically appropriate. As treatment progresses, the focus expands to building healthier habits around nutrition, movement and everyday life. Longer term monitoring and maintenance planning then become important in helping patients sustain the progress they have made.
This approach reflects an important reality of modern obesity care. Reaching a target weight does not necessarily mean that weight management is finished. For many people, maintaining progress can require continued attention to the medical, nutritional and behavioural factors that contributed to their weight in the first place.
Considering GLP-1 weight loss treatment in Jamaica?
If you are already researching GLP-1s, semaglutide, tirzepatide or peptide-based weight loss treatments, the next useful step is determining what those options mean in the context of your own health.
At The Weight Clinic, medical care is led by Dr. Lorenzo Gordon, MD, MPhil, PhD, Diabetologist, Consultant in Internal Medicine and Biochemist. Your care begins with a comprehensive physician consultation in Kingston, where your medical history, weight history, current medications and goals can be assessed before treatment options are discussed.
Physician Consultation: J$10,000
Medical treatment is subject to individual physician assessment. Medication is not appropriate for everyone, individual results vary, and no particular amount or rate of weight loss is guaranteed.
Sources: World Health Organization guideline on GLP-1 therapies for obesity in adults; U.S. Food and Drug Administration guidance on unapproved GLP-1 drugs. Medical treatment is subject to individual assessment.